Synvisc and SynviscOne®

Hyaluronic acid is a naturally occurring substance within the synovial fluid of a joint that acts as a shock absorber, lubricant, and anti–inflammatory agent. Synvisc and Synvisc–One® (hylan G–F 20) are synthetic intra–articular hyaluronic acid injections intended to treat the pain and limitation of motion associated with osteoarthritis of the knee.

The New York State Department of Health conducted an extensive review of the submitted evidence and has determined not to add Synvisc and Synvisc–One® to its Medicaid benefit package at this time. This final coverage determination is based on currently available medical evidence.